ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $16,467,000 | +553.2% | 395,505 | +802.9% | 0.10% | +447.4% |
| Q2 2015 | $2,521,000 | +69.1% | 43,805 | +87.1% | 0.02% | +72.7% |
| Q1 2015 | $1,491,000 | +136.7% | 23,411 | +48.1% | 0.01% | +83.3% |
| Q4 2013 | $630,000 | -3.5% | 15,811 | -9.2% | 0.01% | -25.0% |
| Q3 2013 | $653,000 | +125.2% | 17,411 | +61.4% | 0.01% | +100.0% |
| Q2 2013 | $290,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |